GPT and metabolic dysfunction-associated steatotic liver disease: Studies have confirmed that quercetin can reduce TG levels in circulating supply and endogenous synthesis; prevent excessive TG and its components from deposition in non-adipose tissues, such as the liver; and reduce TC, ALT, and AST levels, thereby improving NAFLD [49].